Sunday, December 3, 2023
Home Internet News BDC

BDC

    Featured posts

    Owl Rock Capital Corp. II Files for Best-Efforts IPO (S&P Global)

    BDC Editor / Curator -
    Owl Rock Capital Corp II has filed a Form N-2 for an initial public offering of up to 150 million of its...
    David Lessen

    Interview with Former UBS Managing Director and Now COO of StHealth Capital David Lessen.

    BDC Editor / Curator -
    While not widely known, Wall Street’s Institutional Investment Managers and Registered Investment Advisors (RIA’s) love using BDC Investment Funds for their clients – to the...

    StHealth Capital, Our #1 Ranked Emerging BDC Idea.

    BDC Editor / Curator -
    Newly Launched Medtech & Biotech BDC Seeking Pre-IPO Stage Investments. This is easily one of the most exciting...
    video

    StHealth Private Equity Medtech Fund. Alternative Investment BDC.

    Video Editor / Curator -
    StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with...

    Former Tesla Foundation Vice Chairman Joins StHealth BDC.

    BDC Editor / Curator -
    St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board...

    Latest article

    Selling Under Cash. LQR House (LQR) Addresses Nasdaq Delisting.

    All News Editor / Curator -
    If You're a Sophisticated Speculator, and we do Mean Sophisticated, Study LQR House (LQR) or 'the Liquor House' Story.

    LQR House (LQR). And the Numbers are In!

    All News Editor / Curator -
    A Situation Which Can't be Ignored! That's not to say run out and buy it, but this current valuation...

    LQR Announces Proposed Reverse Split as Part of Nasdaq Compliance Plan

    Internet News Editor / Curator -
    LIVE QUOTE MIAMI BEACH, FL / ACCESSWIRE / November 21, 2023 / LQR House Inc....
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.